Osmol Therapeutics
Pre-clinicalEnhancing Care, Transforming Lives: Creating compassionate and effective treatment paths for patients at risk of developing chemotherapy-induced peripheral neuropathy (CIPN) and chemotherapy-induced cognitive impairment (CICI).
Founded
2018
Focus
Small Molecules
About
Enhancing Care, Transforming Lives: Creating compassionate and effective treatment paths for patients at risk of developing chemotherapy-induced peripheral neuropathy (CIPN) and chemotherapy-induced cognitive impairment (CICI).
Funding History
2Total raised: $18M
Series A$15MUndisclosedMay 15, 2022
Seed$3MUndisclosedSep 15, 2020
Company Info
TypePrivate
Founded2018
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile